The Sub-Committee on Safety of Medicines (biological) recommended not licensing the Tisseel Kit, a blood product produced by Immuno.
Chronology Information
Date:
Chapter/issue
Blood Products and Addressing Risk: Regulation of Commercial Factor Concentrates